Lauren Merendino

Lauren Merendino is a seasoned commercial leader with over 25 years of pharmaceutical & biotech leadership with expertise in building and leading commercial teams and a record of successful product launches. In her most recent role as Chief Commercial Officer at Myovant Sciences, she led the successful launches of two products across 3 indications. Prior to Myovant, Lauren was the Head of the Neurological Rare Diseases therapeutic area at Genentech where she led a cross-functional team including sales, marketing, access, medical affairs, advocacy, legal and finance. This included the launch of a novel therapy in SMA, which quickly grew to become the market leader. Prior to this role, she led the Commercial Pipeline team for Neuroscience, Rare Diseases, Pediatrics & Anti-infectives. Lauren's career is built on a deep foundation of Marketing, Sales and leadership experience, with a strong record of success across all roles. Lauren has a Bachelors of Science in Microbiology from Penn State University and completed her MBA at New York University.